1. Home
  2. BBAR vs IMCR Comparison

BBAR vs IMCR Comparison

Compare BBAR & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BBAR

Banco BBVA Argentina S.A. ADS

HOLD

Current Price

$18.20

Market Cap

3.7B

Sector

Finance

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$33.64

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBAR
IMCR
Founded
1886
2008
Country
Argentina
United Kingdom
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
1.8B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
BBAR
IMCR
Price
$18.20
$33.64
Analyst Decision
Strong Buy
Buy
Analyst Count
1
10
Target Price
$17.00
$65.33
AVG Volume (30 Days)
582.2K
279.7K
Earning Date
11-25-2025
11-06-2025
Dividend Yield
0.81%
N/A
EPS Growth
N/A
N/A
EPS
0.21
N/A
Revenue
$1,535,146,865.00
$379,590,000.00
Revenue This Year
$0.64
$32.28
Revenue Next Year
$15.77
$10.66
P/E Ratio
$30.08
N/A
Revenue Growth
N/A
28.11
52 Week Low
$7.76
$23.15
52 Week High
$25.01
$40.72

Technical Indicators

Market Signals
Indicator
BBAR
IMCR
Relative Strength Index (RSI) 63.77 37.60
Support Level $17.87 $34.00
Resistance Level $19.08 $36.64
Average True Range (ATR) 0.76 1.50
MACD -0.06 -0.33
Stochastic Oscillator 65.85 10.33

Price Performance

Historical Comparison
BBAR
IMCR

About BBAR Banco BBVA Argentina S.A. ADS

Banco BBVA Argentina SA is a banking services provider in Argentina. It provides financial assistance to large corporations, small and medium-sized companies, as well as individuals. It bank provides services through retail, corporate, investment banking, and Small and medium-sized companies divisions. Through the retail banking segment, it provides banking products and services to individuals, corporate banking deals with services to corporates, and the small and medium-sized companies segment focuses on foreign trade, agricultural business, and digital products.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: